These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31629038)

  • 1. Predicting drug release kinetics from nanocarriers inside dialysis bags.
    Yu M; Yuan W; Li D; Schwendeman A; Schwendeman SP
    J Control Release; 2019 Dec; 315():23-30. PubMed ID: 31629038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. General method for the quantification of drug loading and release kinetics of nanocarriers.
    Schwarzl R; Du F; Haag R; Netz RR
    Eur J Pharm Biopharm; 2017 Jul; 116():131-137. PubMed ID: 28017797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic model and analysis of doxorubicin release from liposomal formulations.
    Fugit KD; Xiang TX; Choi du H; Kangarlou S; Csuhai E; Bummer PM; Anderson BD
    J Control Release; 2015 Nov; 217():82-91. PubMed ID: 26310713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A physiologically-based nanocarrier biopharmaceutics model to reverse-engineer the in vivo drug release.
    Nagpal S; Braner S; Modh H; Tan AXX; Mast MP; Chichakly K; Albrecht V; Wacker MG
    Eur J Pharm Biopharm; 2020 Aug; 153():257-272. PubMed ID: 32589926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable Kinetics for Drug Delivery with a Microfluidic Device Integrated with the Dialysis Bag.
    Esmaeili J; Barati A; Salehi E; Ai J
    Mol Pharm; 2023 Feb; 20(2):1129-1137. PubMed ID: 36652296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A New Method for Evaluating Actual Drug Release Kinetics of Nanoparticles inside Dialysis Devices via Numerical Deconvolution.
    Zhou Y; He C; Chen K; Ni J; Cai Y; Guo X; Wu XY
    J Control Release; 2016 Dec; 243():11-20. PubMed ID: 27693750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of drug release kinetics from nanoparticles: overcoming pitfalls of the dynamic dialysis method.
    Modi S; Anderson BD
    Mol Pharm; 2013 Aug; 10(8):3076-89. PubMed ID: 23758289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the drug release from nanoparticles: Overcoming the shortcomings of dialysis by using novel optical techniques and a mathematical model.
    Xie L; Beyer S; Vogel V; Wacker MG; Mäntele W
    Int J Pharm; 2015 Jul; 488(1-2):108-19. PubMed ID: 25847513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different in vitro release methods used to investigate nanocarriers intended for dermal application.
    Balzus B; Colombo M; Sahle FF; Zoubari G; Staufenbiel S; Bodmeier R
    Int J Pharm; 2016 Nov; 513(1-2):247-254. PubMed ID: 27628784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake and release profiles of PEGylated liposomal doxorubicin nanoparticles: A comprehensive picture based on separate determination of encapsulated and total drug concentrations in tissues of tumor-bearing mice.
    Wang H; Zheng M; Gao J; Wang J; Zhang Q; Fawcett JP; He Y; Gu J
    Talanta; 2020 Feb; 208():120358. PubMed ID: 31816795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Dialysis- and Solvatofluorochromism-Based Methods to Determine Drug Release Rates from Polymer Nanoassemblies.
    Reichel D; Bae Y
    Pharm Res; 2017 Feb; 34(2):394-407. PubMed ID: 27873146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of Cross-linked Poly (N-isopropylacrylamide) Magnetic Nano Composite for Application in the Controlled Release of Doxorubicin.
    Kaamyabi S; Badrian A; Akbarzadeh A
    Pharm Nanotechnol; 2017; 5(1):67-75. PubMed ID: 28948911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid Analysis of DOXIL Stability and Drug Release from DOXIL by HPLC Using a Glycidyl Methacrylate-Coated Monolithic Column.
    Kimoto A; Watanabe A; Yamamoto E; Higashi T; Kato M
    Chem Pharm Bull (Tokyo); 2017; 65(10):945-949. PubMed ID: 28966279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmaceutical and biomedical differences between micellar doxorubicin (NK911) and liposomal doxorubicin (Doxil).
    Tsukioka Y; Matsumura Y; Hamaguchi T; Koike H; Moriyasu F; Kakizoe T
    Jpn J Cancer Res; 2002 Oct; 93(10):1145-53. PubMed ID: 12417045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of polydopamine modified and conventional chemical synthesis method in doxorubicin liposomes form the aspect of tumor targeted therapy.
    Bi D; Zhao L; Li H; Guo Y; Wang X; Han M
    Int J Pharm; 2019 Mar; 559():76-85. PubMed ID: 30677481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled release of doxorubicin from polyethylene glycol functionalized melanin nanoparticles for breast cancer therapy: Part I. Production and drug release performance of the melanin nanoparticles.
    Ozlu B; Kabay G; Bocek I; Yilmaz M; Piskin AK; Shim BS; Mutlu M
    Int J Pharm; 2019 Oct; 570():118613. PubMed ID: 31415880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated hyperbranched polyphosphoester based nanocarriers for redox-responsive delivery of doxorubicin.
    Chen C; Zheng P; Cao Z; Ma Y; Li J; Qian H; Tao W; Yang X
    Biomater Sci; 2016 Mar; 4(3):412-7. PubMed ID: 26626655
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipopepsomes: A novel and robust family of nano-vesicles capable of highly efficient encapsulation and tumor-targeted delivery of doxorubicin hydrochloride in vivo.
    Qiu M; Sun H; Meng F; Cheng R; Zhang J; Deng C; Zhong Z
    J Control Release; 2018 Feb; 272():107-113. PubMed ID: 29355618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer-based liposomes improve specific drug loading and release.
    Plourde K; Derbali RM; Desrosiers A; Dubath C; Vallée-Bélisle A; Leblond J
    J Control Release; 2017 Apr; 251():82-91. PubMed ID: 28238787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.